Evonik Industries AG (EVK)
Industry Specialty Chemicals
This stock can be held in an Investment ISA and an Investment Account
Sell
€13.22
Buy
€13.35
€-0.01 (-0.08%)
Prices updated at 12 Dec 2025, 17:04 CET
| Prices minimum 15 mins delay
Prices in EUR
Evonik Industries AG is a chemical manufacturing company serving its environment-friendly and energy efficient products to nutrition and pharmaceutical sector. Its segments are nutrition and care, resource efficiency, performance materials and services.
-0.53%
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2023 | 2024 |
|---|---|---|
| 15,267m | 15,157m | |
| 2,700m | 3,738m | |
| -99m | 639m | |
| -0.65 | 4.22 | |
| -465m | 222m | |
| 1,734m | 1,763m | |
| Sales, General and administrative | 2,333m | 2,674m |
| Interest expenses | 244m | 212m |
| Provision for income taxes | 101m | 194m |
| Operating expenses | 2,799m | 3,099m |
| Income before taxes | -351m | 434m |
| Net income available to common shareholders | -465m | 222m |
| -1 | 0.48 | |
| Net interest income | -89m | -127m |
| Advertising and promotion | - | - |
| Net investment income, net | -116m | -15m |
| Realised capital gains (losses), net | - | - |
| Total benefits, claims and expenses | - | - |
| Earnings per share (diluted) | -1 | 0.48 |
| Free cash flow per share | 1.8968 | 2.6163 |
| Book value/share | 21.7146 | 19.3519 |
| Debt equity ratio | 0.371717 | 0.326386 |
Balance sheet
Year | 2023 | 2024 |
|---|---|---|
| Current assets | 5,904m | 5,508m |
| Current liabilities | 4,048m | 4,059m |
| Total capital | 11,419m | 11,218m |
| Total debt | 4,247m | 3,781m |
| Total equity | 8,910m | 9,020m |
| Total non current liabilities | - | - |
| Loans | 2,509m | 2,198m |
| Total assets | 19,940m | 19,750m |
| Total liabilities | - | - |
| Cash and cash equivalents | 749m | 461m |
| Common stock | 466m | 466m |
Cash flow
Year | 2023 | 2024 |
|---|---|---|
| Cash at beginning of period | 645m | 749m |
| Cash dividends paid | -545m | -545m |
| 801m | 873m | |
| Investments (gains) losses | -653m | -663m |
| 749m | 461m | |
| Net income | - | - |
| 1,594m | 1,713m | |
| -793m | -840m |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.